A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study.
Document Type
Journal Article
Publication Date
4-1-2008
Journal
Pediatric Blood & Cancer
Volume
50
Issue
4
Inclusive Pages
788-792
DOI
10.1002/pbc.21310
Keywords
Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infant; Infant, Newborn; Leukemia; Male; Maximum Tolerated Dose; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Paclitaxel; Treatment Outcome
APA Citation
Horton, T. M., Ames, M. M., Reid, J. M., Krailo, M. D., Pendergrass, T., Mosher, R., Reaman, G. H., & Seibel, N. L. (2008). A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study.. Pediatric Blood & Cancer, 50 (4). http://dx.doi.org/10.1002/pbc.21310
Peer Reviewed
1
